Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CHRS Coherus Biosciences

盘后交易 12-26 17:46:31 EST

1.49

+0.02

+1.36%

盘后1.47

-0.02-1.34%

16:42 EST

最高1.49	最低1.41	成交量126.62万
今开1.47	昨收1.47	日振幅5.44%
总市值1.72亿	流通市值1.54亿	总股本1.15亿
成交额184.88万	换手率1.23%	流通股本1.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CHRS","market":"US","secType":"STK","nameCN":"Coherus Biosciences","latestPrice":1.49,"timestamp":1735246800000,"preClose":1.47,"halted":0,"volume":1266232,"hourTrading":{"tag":"盘后","latestPrice":1.4701,"preClose":1.49,"latestTime":"16:42 EST","volume":2352,"amount":3498.6214032000003,"timestamp":1735249352952},"delay":0,"floatShares":103295317,"shares":115213407,"eps":-0.003959,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.02,"latestTime":"12-26 17:46:31 EST","open":1.47,"high":1.49,"low":1.41,"amount":1848808.3756912,"amplitude":0.054422,"askPrice":1.48,"askSize":1100,"bidPrice":1.45,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-0.003959,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735261200000},"adr":0,"listingDate":1415250000000,"adjPreClose":1.47,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.4694,"preClose":1.47,"latestTime":"09:29 EST","volume":6494,"amount":9423.7927772,"timestamp":1735223342892},"postHourTrading":{"tag":"盘后","latestPrice":1.4701,"preClose":1.49,"latestTime":"16:42 EST","volume":2352,"amount":3498.6214032000003,"timestamp":1735249352952},"volumeRatio":0.443627,"impliedVol":0.8821,"impliedVolPercentile":0.2302},"requestUrl":"/m/hq/s/CHRS/tweets","defaultTab":"tweets","newsList":[{"id":"2493707080","title":"Coherus Biosciences, Inc.盘中异动 早盘急速下跌5.24%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493707080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493707080?lang=zh_cn&edition=full","pubTime":"2024-12-24 22:55","pubTimestamp":1735052126,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日22时55分，Coherus Biosciences, Inc.股票出现波动，股价急速跳水5.24%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。该公司在美国销售 Neulasta 的生物仿制药，UDENYCA，并预计于 2023 年在美国推出 FDA 批准的 Humira 生物仿制药 YUSIMRY。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224225526ab90bf75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224225526ab90bf75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2493976100","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.26%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493976100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493976100?lang=zh_cn&edition=full","pubTime":"2024-12-23 23:16","pubTimestamp":1734966966,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日23时16分，Coherus Biosciences, Inc.股票出现异动，股价快速下跌5.26%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223231607984d3c4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223231607984d3c4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2492444404","title":"Coherus Biosciences, Inc.盘中异动 急速跳水5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492444404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492444404?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:33","pubTimestamp":1734705234,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时33分，Coherus Biosciences, Inc.股票出现波动，股价快速下跌5.34%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Humacyte, Inc.、Humacyte Inc C/Wts 27/08/2026 、Aptose Biosciences, Inc.涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Aditxt, Inc.较为活跃，换手率分别为1758.12%、79.65%、54.95%，振幅较大的相关个股有Humacyte, Inc.、Quoin Pharmaceuticals Ltd、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为31.21%、30.92%、28.80%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223355a1fe2527&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223355a1fe2527&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2492309111","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.00%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492309111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492309111?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:07","pubTimestamp":1734548838,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时07分，Coherus Biosciences, Inc.股票出现波动，股价急速跳水5.00%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.32%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219030718ab8278fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219030718ab8278fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2491061310","title":"Coherus Biosciences, Inc.盘中异动 快速上涨5.28%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491061310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491061310?lang=zh_cn&edition=full","pubTime":"2024-12-16 23:34","pubTimestamp":1734363275,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日23时34分，Coherus Biosciences, Inc.股票出现波动，股价大幅拉升5.28%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216233436a1f360d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216233436a1f360d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2491379837","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.00%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491379837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491379837?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:52","pubTimestamp":1734101534,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日22时52分，Coherus Biosciences, Inc.股票出现异动，股价急速上涨5.00%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225214984bd7b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213225214984bd7b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2491336818","title":"Coherus Biosciences, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491336818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491336818?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:11","pubTimestamp":1734019900,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时11分，Coherus Biosciences, Inc.股票出现异动，股价快速下跌5.15%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213001140984b9ac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213001140984b9ac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2490864175","title":"Coherus Biosciences, Inc.盘中异动 早盘快速下挫5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490864175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490864175?lang=zh_cn&edition=full","pubTime":"2024-12-11 23:58","pubTimestamp":1733932699,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日23时58分，Coherus Biosciences, Inc.股票出现波动，股价大幅跳水5.28%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211235819984b59be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211235819984b59be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2490702641","title":"Coherus Biosciences, Inc.盘中异动 急速下挫5.29%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490702641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490702641?lang=zh_cn&edition=full","pubTime":"2024-12-11 04:54","pubTimestamp":1733864066,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日04时54分，Coherus Biosciences, Inc.股票出现波动，股价急速下挫5.29%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211045426ab6d947c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211045426ab6d947c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2490737267","title":"Coherus Biosciences, Inc.盘中异动 股价大涨5.59%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490737267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490737267?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:34","pubTimestamp":1733754895,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时34分，Coherus Biosciences, Inc.股票出现波动，股价大幅上涨5.59%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223455ab6a0b8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223455ab6a0b8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2489128231","title":"Coherus Biosciences, Inc.盘中异动 快速上涨5.30%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489128231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489128231?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:01","pubTimestamp":1733497284,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时01分，Coherus Biosciences, Inc.股票出现异动，股价快速上涨5.30%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230124971c2656&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206230124971c2656&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","CHRS","BK4139"],"gpt_icon":0},{"id":"2489210457","title":"Coherus Biosciences, Inc.盘中异动 快速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489210457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489210457?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:30","pubTimestamp":1733409028,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时30分，Coherus Biosciences, Inc.股票出现异动，股价急速上涨5.26%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522302898e59db0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120522302898e59db0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0},{"id":"2488019242","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大涨9.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488019242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488019242?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:32","pubTimestamp":1733322741,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时32分，Coherus Biosciences, Inc.股票出现波动，股价快速上涨9.97%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223221a26c5e1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223221a26c5e1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","CHRS"],"gpt_icon":0},{"id":"2488249239","title":"嗡嗡声--美国股票走势-PSQ Holdings、Core Scientific、Keros","url":"https://stock-news.laohu8.com/highlight/detail?id=2488249239","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488249239?lang=zh_cn&edition=full","pubTime":"2024-12-04 02:41","pubTimestamp":1733251314,"startTime":"0","endTime":"0","summary":"** Credo Technology Group Holding Ltd   : BUZZ - 因第二季度销售额超出预期而大涨   ** Janux Therapeutics Inc   : BUZZ - 因癌症药物的早期数据超出预期而飙升。** Core Scientific Inc   : BUZZ - 在扩大 5.5 亿美元可转换债券发行规模后上涨   ** Keros Therapeutics Inc   : BUZZ - 与武田达成血癌药物许可协议后上涨   ** AT&T Inc   : BUZZ - 在实施扩张计划和提高指导后创下 3 年半新高   ** Rio Tinto PLC   ：** BHP Group Ltd   ：** Southern Copper Corp   ：** Freeport-McMoRan Inc   : BUZZ - 铜矿企业因美元走软而上涨   ** Avadel Pharmaceuticals PLC   : BUZZ - 在首席商务官辞","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INTC","CTRN","FDX","JANX","JBGS","ZS","UDOW","CPNG","AVDL","TERN","TRGP",".DJI",".SPX","DECK","KR","LTRN","FDN","BLK","LYV","AXON","DDM","FCX","ROIV","DXD","ADM","AZO","MOH","OLLI","DJX","CORZ","EQT","NEM","CUZ",".IXIC","PSQH","T","SDOW","DOG","KROS","CVX","MP","SCCO","X","CHRS","XOM"],"gpt_icon":1},{"id":"2488942699","title":"嗡嗡声--美国股票走势-贝莱德、Terns Pharma、PSQ Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2488942699","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488942699?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:50","pubTimestamp":1733241022,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30，道琼斯工业平均指数.DJI下跌0.29%，报44,650.91点；标准普尔500指数.SPX下跌0.20%，报6,034.81点；纳斯达克综合指数.IXIC下跌0.10%，报19,384.43点。标准普尔500指数.PG.INX涨幅前三名是： ** Palantir Technologies Inc PLTR.OQ，上涨 5.4. nL3N3N414G  ** Credo Technology Group Holding Ltd CRDO.O:BUZZ - 因第二季度销售额超出预期而大涨 nL3N3N40QR  ** Janux Therapeutics Inc JANX.O:BUZZ - 因癌症药物的早期数据超出预期而飙升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N419A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANG","BK4168","DECK","AXON","LTRN","CRDO","CZR","OLLI","NEM","XCUR","CHRS","ATIP","MPLN","TCS","IE00B4R5TH58.HKD","BLK","OMEX","CPNG","PCG","BK4114","LU1861220033.SGD","PSQH","CTXR","AMGN","LU2430703095.HKD","IE00BJJMRZ35.SGD","MP","ROIV","X","LU2125909759.SGD","LU2264538146.SGD","LYV","BK4187","FDX","JANX","T","ZS","KR","LU1923622291.USD","LEV","AZO","CTRN","TERN","BK4135","CTNT","MCHP"],"gpt_icon":1},{"id":"2488945715","title":"Coherus Biosciences, Inc.盘中异动 股价大涨46.72%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488945715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488945715?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:31","pubTimestamp":1733236278,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时31分，Coherus Biosciences, Inc.股票出现波动，股价大幅拉升46.72%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223119abf2f842&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223119abf2f842&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CHRS","BK4535"],"gpt_icon":0},{"id":"2488491948","title":"嗡嗡声--美国股票走势-花旗趋势、PG&E、贝莱德","url":"https://stock-news.laohu8.com/highlight/detail?id=2488491948","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488491948?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:05","pubTimestamp":1733234739,"startTime":"0","endTime":"0","summary":"nL3N3N40QR  ** Janux Therapeutics Inc JANX.O:BUZZ - 因癌症药物的早期数据超出预期而飙升。nL3N3N40RX  ** FedEx Corp FDX.N:BUZZ - 伯恩斯坦在发布第二季度财报前将联邦快递的评级下调至 \"市场表现\"。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3S3N410V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","BK4539","LTRN","LU1861215975.USD","LU1064131342.USD","KR","LU2242652126.USD","ZS","BK4559","LYV","LU0724618789.USD","LU0320765489.SGD","AMGN","BK4097","CTNT","CRDO","BK4535","JANX","LU0109394709.USD","MP","LU2112291526.USD","BLK","LU1430597077.USD","ROIV","BK4533","IE00BFTCPJ56.SGD","LU0345770308.USD","BK4159","NEM","AXON","LU2264538146.SGD","DECK","LU0122379950.USD","X","LU1670627923.USD","IE00B3PB1722.GBP","LU0300736062.USD","CTRN","CHRS","LU0070302665.USD","LU1280957306.USD","LU1989771016.USD","BK4170","LU0390134368.USD","LU0788109121.HKD","FDX","PCG","LU0345770993.USD","LU0251142724.SGD"],"gpt_icon":0},{"id":"2488911107","title":"BUZZ-Coherus生物公司因剥离安进公司Neulasta生物仿制药的交易而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2488911107","media":"路透中文","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488911107?lang=zh_cn&edition=full","pubTime":"2024-12-03 20:47","pubTimestamp":1733230053,"startTime":"0","endTime":"0","summary":"BUZZ-Coherus生物公司因剥离安进公司Neulasta生物仿制药的交易而跃升12月3日 -  ** Coherus BioSciences CHRS.O股价盘前大涨20%至1.64美元 ** 在与印度Intas Pharmaceuticals公司的交易中，该公司将以高达5.584亿美元的价格出售其生物仿制药Udenyca，其中包括4.834亿美元的预付款。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241203:nL3T3N40VT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","IE0009355771.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0889565916.HKD","BK4139","BK4585","LU1023059063.AUD","LU0320765992.SGD","LU1571399168.USD","BK4534","IE0002141913.USD","BK4588","BK4535","BK4599","CHRS","IE00BJJMRZ35.SGD","LU0109394709.USD","AMGN","BK4533","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4581","LU0122379950.USD","LU1057294990.SGD","LU2242652126.USD","LU2242646821.SGD","LU0058720904.USD","LU1061106388.HKD","LU2112291526.USD","LU0289739699.SGD","BK4566","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2488767213","title":"Coherus Biosciences, Inc.盘中异动 早盘股价大涨5.33%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488767213","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488767213?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:42","pubTimestamp":1733150524,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时42分，Coherus Biosciences, Inc.股票出现波动，股价快速上涨5.33%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224204a2669eee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202224204a2669eee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CHRS","BK4535","BK4139"],"gpt_icon":0},{"id":"2486723908","title":"Coherus Biosciences, Inc.盘中异动 临近午盘股价大涨5.08%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486723908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486723908?lang=zh_cn&edition=full","pubTime":"2024-11-28 00:50","pubTimestamp":1732726249,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日00时50分，Coherus Biosciences, Inc.股票出现波动，股价快速上涨5.08%。Coherus Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Coherus Biosciences, Inc.公司简介：Coherus BioSciences Inc 是一家商业阶段的生物制药公司，利用 FDA 批准的多元化疗法组合产生的现金，资助建立免疫肿瘤学特许经营权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128005049a25a2f28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128005049a25a2f28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","CHRS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.coherus.com","stockEarnings":[{"period":"1week","weight":-0.1404},{"period":"1month","weight":0.3486},{"period":"3month","weight":0.4835},{"period":"6month","weight":-0.1353},{"period":"1year","weight":-0.2723},{"period":"ytd","weight":-0.5586}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.1005},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.2651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Coherus Biosciences, Inc.于2010年9月在特拉华州注册成立。该公司是一家商业阶段的生物制药公司，专注于创新癌症治疗的研究、开发和商业化以及已获批准的生物类似物组合的商业化。该公司的战略是建立一个领先的免疫肿瘤专营权，其资金来自通过净销售美国食品和药物管理局批准的疗法的多元化组合所产生的现金。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.01531},{"month":2,"riseRate":0.5,"avgChangeRate":0.011849},{"month":3,"riseRate":0.5,"avgChangeRate":0.031914},{"month":4,"riseRate":0.5,"avgChangeRate":-0.06174},{"month":5,"riseRate":0.5,"avgChangeRate":-0.005756},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013481},{"month":7,"riseRate":0.5,"avgChangeRate":0.086566},{"month":8,"riseRate":0.8,"avgChangeRate":0.10749},{"month":9,"riseRate":0.1,"avgChangeRate":-0.143671},{"month":10,"riseRate":0.3,"avgChangeRate":-0.071307},{"month":11,"riseRate":0.5,"avgChangeRate":0.013066},{"month":12,"riseRate":0.545455,"avgChangeRate":0.04702}],"exchange":"NASDAQ","name":"Coherus Biosciences","nameEN":"Coherus BioSciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Coherus Biosciences,CHRS,Coherus Biosciences股票,Coherus Biosciences股票老虎,Coherus Biosciences股票老虎国际,Coherus Biosciences行情,Coherus Biosciences股票行情,Coherus Biosciences股价,Coherus Biosciences股市,Coherus Biosciences股票价格,Coherus Biosciences股票交易,Coherus Biosciences股票购买,Coherus Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Coherus Biosciences(CHRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Coherus Biosciences(CHRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}